Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation.
about
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignanciesFludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemiaDesialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.Prior exposure to imatinib does not impact outcome of allogeneic hematopoietic transplantation for chronic myeloid leukemia patients: a single-center experience in chinaHematopoietic stem cell transplantation in China: current status and prospectsMolecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions.Association of human leukocyte antigen haplotypes with clearance and persistence of hepatitis B virus infection in northeastern China.Impact of pre-transplant disease burden on the outcome of allogeneic hematopoietic stem cell transplant in refractory and relapsed acute myeloid leukemia: a single-center study.Engineering haploidentical transplants.The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation.The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.
P2860
Q26748867-EE7D5E30-1F90-405D-B29C-C30E9D39B88AQ27014857-68DE9933-FE90-46C6-AEA6-9420A3BB8D8DQ30276948-3C79D568-3614-4FBE-8F6F-753FB4EB8748Q33427006-115334E0-8830-4BAC-96EC-E92522B50EB2Q35480678-EDE6ACEC-013B-47BF-9591-560BE86E722EQ35824935-8A06E143-571F-4648-B551-8F0EA4F8EE98Q38002109-95DABCC8-F793-4D82-8C11-0AC0441A036DQ38035452-5E7B0B87-0FD1-4122-9CCA-FEF97BA8D58FQ38124285-73FF682F-EBFE-49CB-BA74-7777402654A9Q38953608-666B2E66-D439-457B-92AC-120B150E5FD1Q39006094-21C6DC0E-139D-42CD-95F7-330BDC356783Q41542632-23219153-33D7-4D68-BDE1-8B1CB02AB822Q44140205-AA669622-A051-44DF-A2BF-33208799CD86Q45875855-AA6E30C1-0C70-44AD-B23A-54D24FE0E58DQ50863410-A5203ED7-1167-4CE2-9B76-C8BC3F19CC19Q52678836-A2C3CABE-56D7-4391-9AC4-F96E89FA31DF
P2860
Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unmanipulated HLA-mismatched/h ...... tic stem cell transplantation.
@en
Unmanipulated HLA-mismatched/h ...... tic stem cell transplantation.
@nl
type
label
Unmanipulated HLA-mismatched/h ...... tic stem cell transplantation.
@en
Unmanipulated HLA-mismatched/h ...... tic stem cell transplantation.
@nl
prefLabel
Unmanipulated HLA-mismatched/h ...... tic stem cell transplantation.
@en
Unmanipulated HLA-mismatched/h ...... tic stem cell transplantation.
@nl
P1476
Unmanipulated HLA-mismatched/h ...... etic stem cell transplantation
@en
P2093
Ying-Jun Chang
P304
P356
10.1016/J.BBMT.2010.03.006
P577
2010-03-17T00:00:00Z